Zobrazeno 1 - 10 of 89 pro vyhledávání: '"C. Calvo Gómez"'
1
Hipertrofia ventricular izquierda y variación circadiana de la presión arterial
Autor: JE Lopez Paz, A. Hermida Ameijeiras, C. Calvo Gómez, J.R. González Juanatey, S. Cinza Sanjurjo
Publikováno v: RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)
Antecedentes y objetivos Son multiples los estudios que avalan el papel pronostico que han mostrado tanto la presion arterial (PA) ambulatoria como la hipertrofia ventricular izquierda (HVI) en el paciente hipertenso. Por ello, nos planteamos evaluar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65326088ddbc354ac39d687a51f565f5
https://doi.org/10.1016/j.hipert.2013.05.005
Zobrazit plný text záznamu
2
Liraglutida en el tratamiento de la diabetes tipo 2
Autor: M. Puig Domingo, J. Navarro Pérez, F.J. Ampudia-Blasco, X. Cos Claramunt, J.J. Mediavilla Bravo, J. García Alegría, P. Mezquita Raya, C. Calvo Gómez, E. Jódar Gimeno
Publikováno v: Avances en Diabetología. 26:226-234
Liraglutide is the first once daily human glucagonlike peptide-1 (GLP-1) analogue, with a 97% homology. Liraglutide has recently been approved by the European Medicines Agency and by the Food and Drug Administration to be used in the medical manageme
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34b22c31dd20a1ab629519a41a4458cd
https://doi.org/10.1016/s1134-3230(10)64003-3
Zobrazit plný text záznamu
3
HYDRA
Autor: Marcos Ortega, A. Hermida Ameijeiras, Noelia Barreira, José Enrique López Paz, C. Calvo Gómez, Manuel G. Penedo, Jorge Novo
Publikováno v: Journal of Hypertension. 36:e264
Objective:The cardiovascular risk (CV) assessment is a very complex process and requires a large set of data necessary for clinical decision (diabetes, obesity, clinical analysis, electrocardiogram, etc.).The web system, called Hydra, integrates a co
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a12df19abe0458b4a9fd773eabb27a8
https://doi.org/10.1097/01.hjh.0000539757.81385.f8
Zobrazit plný text záznamu
5
ADMINISTRATION-TIME-DEPENDENT EFFECTS OF CANAGLIFLOZIN IN TYPE 2 DIABETIC PATIENTS AND ARTERIAL HYPERTENSION
Autor: José Enrique López Paz, C. Calvo Gómez, S. Fernandez-Crespo, Álvaro Hermida Ameijeiras, I. Rodriguez
Publikováno v: Journal of Hypertension. 36:e190
Objective:Nocturnal hypertension is more frequent in diabetics, due to the dysfunction of the autonomic nervous system. Several prospective studies have concluded that nocturnal BP is a better predictor of CV mortality than daytime BP or even, than t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34b3b1e6f07e1340bd2d3a9798d45f32
https://doi.org/10.1097/01.hjh.0000539525.27600.ea
Zobrazit plný text záznamu
6
[Carotid intima-media thickness distribution according to the stratification of cardiovascular risk by means of Framingham-REGICOR and score function charts]
Autor: Á, Hermida-Ameijeiras, J E, López-Paz, M A, Riveiro-Cruz, C, Calvo-Gómez
Publikováno v: Hipertension y riesgo vascular. 33(2)
Carotid intima-media thickness (cIMT) has been suggested as a further tool for risk function charts. The aim of this study was to describethe relationship between cIMT and cardiovascular risk (CVR) estimation according to Framingham-REGICOR and SCORE
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::383eaafeb7d98dad8199a005ba866478
https://pubmed.ncbi.nlm.nih.gov/26796100
Zobrazit plný text záznamu
7
Cronobiología y cronoterapia en la hipertensión arterial: implicaciones diagnósticas, pronósticas y terapéuticas
Autor: R. C. Hermida Domínguez, C. Calvo Gómez, D.E. Ayala García
Publikováno v: Hipertensión y Riesgo Vascular. 21:256-270
La presion arterial se caracteriza por una marcada variacion circadiana. La cronoterapia de la hipertension arterial toma en cuenta los aspectos clinicos relevantes de la variacion de la presion arterial a lo largo del dia; en concreto, la elevacion
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::66a5e6af8557bfd1b5529d6acc0110e9
https://doi.org/10.1016/s1889-1837(04)71485-3
Zobrazit plný text záznamu
8
Eficacia y tolerabilidad de irbesartán en pacientes con hipertensión arterial y diabetes mellitus tipo 2
Autor: S. Tranche Iparraguirre, R. Marín Iranzo, L. Rodríguez Mañas, C. Calvo Gómez, S. Armengol Bertolín, J. Abellán Alemán, P. Aranda Lara, A Coca Payeras
Publikováno v: Hipertensión y Riesgo Vascular. 20:252-258
Fundamento La coexistencia de hipertension arterial (HTA) y diabetes tipo 2 constituye una combinacion de incidencia creciente y de elevado riesgo cardiovascular. El bloqueo del sistema renina angiotensina con inhibidores de la enzima convertidora (I
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::077d7494e21fa35f75043b746809d11b
https://doi.org/10.1016/s1889-1837(03)71397-x
Zobrazit plný text záznamu
9
[Comparison of the cardiovascular predictive value of MDRD and CKD-EPI in estimating chronic kidney disease]
Autor: S, Cinza-Sanjurjo, C, Calvo-Gómez, A, Hermida-Ameijeiras, J E, López-Paz, J R, González-Juanatey
Publikováno v: Semergen. 42(1)
To assess predictive value of the cardiovascular prognosis by comparing the two most used formulas for the estimation of glomerular filtration rate in hypertensive patients.A retrospective cohort study was designed that included 405 patients diagnose
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f14dfcbca3b5e70dd3238944a839d595
https://pubmed.ncbi.nlm.nih.gov/25510591
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje